Stock KNSA KINIKSA PHARMACEUTICALS, LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Kiniksa Pharmaceuticals, Ltd.

Equities

KNSA

BMG5269C1010

Real-time Estimate Cboe BZX
Other stock markets
 10:34:46 2024-05-24 am EDT 		5-day change 1st Jan Change
19.35 USD +0.94% Intraday chart for Kiniksa Pharmaceuticals, Ltd. -2.28% +10.15%
May. 14 Transcript : Kiniksa Pharmaceuticals, Ltd. Presents at Bank of America Health Care Conference 2024, May-14-2024 10:40 AM
Apr. 23 Kiniksa Pharmaceuticals Q1 Loss Widens, Revenue Rises MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Kiniksa Pharmaceuticals to Present at Bank of America Securities 2024 Health Care Conference
AQ
Kiniksa Pharmaceuticals Reports First Quarter 2024 Financial Results and Recent Portfolio Execution
AQ
Kiniksa Pharmaceuticals to Report First Quarter 2024 Financial Results on April 23, 2024
AQ
Kiniksa Pharmaceuticals Announces Development Indication for Abiprubart
AQ
PRACTICE STATEMENT LETTER PROPOSED SCHEME OF ARRANGEMENT IN RESPECT OF: KINIKSA PHARMACEUTICALS, LTD - Form 8-K
PU
Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Portfolio Execution
AQ
Kiniksa Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024
AQ
Kiniksa Pharmaceuticals Provides Corporate Update
AQ
Kiniksa Pharmaceuticals to Present at 42nd Annual J.P. Morgan Healthcare Conference
AQ
Kiniksa Pharmaceuticals Reports Third Quarter 2023 Financial Results and Recent Portfolio Execution
AQ
Kiniksa Pharmaceuticals to Report Third Quarter 2023 Financial Results on October 31, 2023
AQ
Kiniksa Pharmaceuticals Reports Second Quarter 2023 Financial Results and Recent Portfolio Execution
AQ
Kiniksa Pharmaceuticals to Report Second Quarter 2023 Financial Results on July 25, 2023
AQ
Kiniksa Pharmaceuticals : 2022 Annual Report
PU
Kiniksa Pharmaceuticals : 2023 Proxy Statement
PU
Kiniksa Pharmaceuticals to Present at Goldman Sachs 44th Annual Global Healthcare Conference
AQ
KINIKSA PHARMACEUTICALS, LTD. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
Kiniksa Pharmaceuticals Reports First Quarter 2023 Financial Results and Recent Portfolio Execution
AQ
Kiniksa Pharmaceuticals to Report First Quarter 2023 Financial Results on May 2, 2023
AQ
KINIKSA PHARMACEUTICALS, LTD. : Regulation FD Disclosure (form 8-K)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. KNSA Stock
  4. News Kiniksa Pharmaceuticals, Ltd.
  5. Press Releases